Putting the Patient First: Advancing Biopharma Innovation and Industry Transformation

putting-patient-first

Norstella is driven by its mission: Helping patients gain access to life-saving therapies by transforming the drug development journey. Norstella is working to fulfill this mission in a challenging landscape for pharmaceutical, medtech, and clinical research organizations. With this as the context, Norstella recently held a recent roundtable discussion in London featuring several members of […]

Obesity R&D in 2024 & Beyond: Key Considerations in an Increasingly Competitive Landscape

obesity-rd

Norstella empowers stakeholders involved in obesity drug development to make informed decisions based on trusted industry data and expert insights. This infographic uses some of those data and insights to demonstrate the various complex factors that continue to impact obesity R&D, assess expectations for future development in this space, and emphasize how Norstella serves as […]

Unlocking Success in the Evolving Pharma Landscape: Insights from Norstella’s Daniel Chancellor

evolving-pharma-landscape

Recent breakthroughs in obesity, Alzheimer’s, and other major disease areas are reshaping pharma R&D priorities and forcing companies to rethink pipeline strategy, payer value communication, and long-term growth. The discussion highlights the importance of learning from both drug development successes and failures, while emphasizing emerging opportunities in areas like cell, gene, and RNA therapies, as […]

Paving the Way for Women in Life Sciences

Paving-way-women-life-sciences

The ultimate success of the life sciences industry is highly dependent on a diverse workforce of pioneers, collaborators, and change-drivers, though there is still progress to be made with regard to gender equality in this field. Life sciences organizations are thus exploring ways to best prioritize diversity, including how to advocate for equality among leadership […]

Norstella Brands